Recommending HPV vaccination at age 9 to reduce health disparities: Communication challenges and opportunities
The HPV vaccine is approved for children as young as age nine and recommended by the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices routinely for ages 11–12. However, many U.S. adolescents do not complete the vaccine series until middle to late adolescence,...
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | English |
| Publicado: |
Taylor & Francis Group
2023-01-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Acceso en liña: | http://dx.doi.org/10.1080/21645515.2023.2178219 |